Dr. Gupta graduated from the Maulana Azad Med Coll, Delhi Univ, New Delhi, Delhi, India in 1983. He works in Panorama City, CA and 1 other location and specializes in Cardiovascular Disease. Dr. Gupta is affiliated with Mission Community Hospital and Providence Holy Cross Medical Center.
Dr. Gupta graduated from the Maulana Azad Med Coll, Delhi Univ, New Delhi, Delhi, India in 1990. He works in Leesburg, FL and 2 other locations and specializes in Internal Medicine. Dr. Gupta is affiliated with Florida Hospital Waterman, Leesburg Regional Medical Center and The Villages Regional Hospital.
Dr. Gupta graduated from the Gajra Raja Med Coll, Jiwaji Univ, Gwalior, Mp, India in 1986. He works in Chandler, AZ and specializes in Hospitalist and Internal Medicine. Dr. Gupta is affiliated with Banner Baywood Medical Center, Banner Heart Hospital, Chandler Regional Medical Center and Mercy Gilbert Medical Center.
Jun 2010 to Present Co-founderPhoenix Technologies Ltd Phoenix, AZ Apr 2007 to Oct 2009 Vice President and General Manager, FailSafe ProductsLynuxWorks Inc HP, IN 1996 to 2007 Director of Engineering & professional ServicesISDCorp
1996 to 2000 Director of EngineeringHewlett Packard HP, IN 1995 to 1996 Senior Software ConsultantDefense R&D Organization
1989 to 1994 India - Research Scientist
Education:
University of Indore Indore, Madhya Pradesh 1989 Master of Science in Computer ScienceUniversity of Delhi Delhi, Delhi 1987 Bachelor of Science in Mathematics
The B.1.617 variant has spread rapidly in parts of India, apparently dominating over previously circulating viruses in some parts of the country, said Ravi Gupta, professor of clinical microbiology at the University of Cambridge, who is studying these variants. B.1.1.7 is dominating in some parts
Date: Apr 30, 2021
Category: More news
Source: Google
'Double Mutant' Variant In India Shouldn't Really Be Called That, Scientists Say : Goats and Soda
So, most likely, COVD-19 vaccines will still work against B1.617, but they could be slightly less effective, Cambridge University's Ravi Gupta said on Twitter: "Likely vaccines will protect against severe illness and death but not against infection in those [people] with poorer immune responses."
Date: Apr 24, 2021
Category: Headlines
Source: Google
Why The Coronavirus Variant From Brazil Is Especially Worrisome To Scientists : Goats and Soda
And thus, now we have a game of "cat and mouse," said virus expert Ravi Gupta, between the virus and the vaccine. The virus finds ways around the vaccine (and our immune system), said Gupta, and so the manufacturers have to reformulate the vaccines (or else we run the risk of getting infected twice)
Date: Jan 27, 2021
Category: More news
Source: Google
New coronavirus variant may have been in US since October
Even if the variant identified by Helix isnt B117, the nature of some of the mutations it contains are concerning, because they may increase the viruss ability to infect human cells, added Ravi Gupta, a professor of clinical microbiology at the University of Cambridge, UK, who helped sequence the
Date: Jan 01, 2021
Category: More news
Source: Google
Britain's Supercharged Mutant Coronavirus Expected to Go Global
uggest that the approved vaccines wont work against the mutation, but that doesnt mean scientists arent concerned about that prospect. Ravi Gupta, professor of clinical microbiology at the University of Cambridge, told BBC News: If we let it add more mutations, then you start worrying... This vi
Date: Dec 21, 2020
Category: More news
Source: Google
EXPLAINER: Are new coronavirus strains cause for concern?
Im worried about this, for sure, but its too soon to know how important it ultimately will prove to be, said Dr. Ravi Gupta, who studies viruses at the University of Cambridge in England. He and other researchers posted a report of it on a website scientists use to quickly share developments, bu
Date: Dec 20, 2020
Category: More news
Source: Google
As opioid deaths rise, pharma firm hikes price of antidote more than six-fold
Theres a lot of value to this formulation, said Ravi Gupta, a medical student and lead author of a December op-ed on the pricing issue, published in the New England Journal of Medicine. But its not justified. This pricing is not justified.
part of our armamentarium against HIV, so it is extremely concerning to see such a high level of resistance to this drug," explains lead author Dr. Ravi Gupta (UCL Infection & Immunity), who is also an Honorary Consultant in Infectious Diseases at University College London NHS Foundation Trust.
Lindy Huntington, Hans Wright, Ragan Fairchild, Benjamin Salisbury, Christene Main, Terra Herzberger, Andrew Korkunov, Shahla Geoffrey, Upinder Fnu, Mark Carey, Reda Jaafari